HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise in tough childhood cancer
Disease control CompletedThis phase 3 trial tested the safety of giving a monoclonal antibody (dinutuximab) along with immune-boosting drugs and a vitamin-like drug to children with high-risk neuroblastoma after a stem cell transplant. The goal was to see if this combination could be given safely and hel…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immunotherapy combo shows promise for tough childhood cancer
Disease control CompletedThis study tested whether adding two immunotherapy drugs (dinutuximab and GM-CSF) to standard chemotherapy is safe and doable for children newly diagnosed with high-risk neuroblastoma. Forty-two children took part. The goal was to see if the extra drugs cause too many side effect…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC